An Inflammation-responsive Hydrogel for Drug Delivery for Treatment of Ulcerative Colitis

摘要

This site-specific, inflammation-responsive delivery approach harnesses the advantages of local drug delivery (reduced systemic toxicity) while overcoming existing limitations (need for frequent drug administrations). These studies have established a proof of concept in pre-clinical UC mouse models that should serve as useful data for future studies towards clinical implementation.